InspireMD (NSPR) Revenue Growth (5y) (2015 - 2025)
InspireMD (NSPR) Revenue Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | InspireMD | 44.38 Mn | -9.83 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81.93% |
| Sep 30, 2025 | 20.82% |
| Jun 30, 2025 | 41.54% |
| Mar 31, 2025 | 8.14% |
| Dec 31, 2024 | 13.98% |
| Sep 30, 2024 | 14.03% |
| Jun 30, 2024 | 5.13% |
| Mar 31, 2024 | 29.49% |
| Dec 31, 2023 | 16.46% |
| Sep 30, 2023 | 15.14% |
| Jun 30, 2023 | 10.45% |
| Mar 31, 2023 | 4.23% |
| Dec 31, 2022 | 4.23% |
| Sep 30, 2022 | 14.79% |
| Jun 30, 2022 | 19.06% |
| Mar 31, 2022 | 15.76% |
| Dec 31, 2021 | 33.78% |
| Sep 30, 2021 | 17.96% |
| Jun 30, 2021 | 13.96% |
| Mar 31, 2021 | 12.31% |